Cargando…
RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis
Transthyretin (TTR) is a tetrameric protein synthesized primarily by the liver. TTR can misfold into pathogenic ATTR amyloid fibrils that deposit in the nerves and heart, causing a progressive and debilitating polyneuropathy (PN) and life-threatening cardiomyopathy (CM). Therapeutic strategies, whic...
Autores principales: | Ioannou, Adam, Fontana, Marianna, Gillmore, Julian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933836/ https://www.ncbi.nlm.nih.gov/pubmed/36795354 http://dx.doi.org/10.1007/s40259-023-00577-7 |
Ejemplares similares
-
Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020) -
Liver‐directed drugs for transthyretin‐mediated amyloidosis
por: Brannagan, Thomas H., et al.
Publicado: (2022) -
Imaging-Guided Treatment for Cardiac Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2022) -
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)